E3 ubiquitin ligases and deubiquitinases in bladder cancer tumorigenesis and implications for immunotherapies

M Wang, Z Zhang, Z Li, Y Zhu, C Xu - Frontiers in Immunology, 2023 - frontiersin.org
With the rapidly increasing incidence of bladder cancer in China and worldwide, great efforts
have been made to understand the detailed mechanism of bladder cancer tumorigenesis …

NCAPD3 enhances Warburg effect through c-myc and E2F1 and promotes the occurrence and progression of colorectal cancer

Z Jing, Q Liu, X He, Z Jia, Z Xu, B Yang… - Journal of Experimental & …, 2022 - Springer
Background NCAPD3 is one of the three non-SMC subunits of condensin II complex, which
plays an important role in the chromosome condensation and segregation during mitosis …

[HTML][HTML] RNA methylation, homologous recombination repair and therapeutic resistance

Y Bai, H Zhao, H Liu, W Wang, H Dong… - Biomedicine & …, 2023 - Elsevier
Homologous recombination (HR) repair of DNA double-strand breaks (DSBs) is critical for
maintaining genomic integrity and stability. Defects in HR increase the risk of tumorigenesis …

RNF126‐Mediated MRE11 Ubiquitination Activates the DNA Damage Response and Confers Resistance of Triple‐Negative Breast Cancer to Radiotherapy

W Liu, M Zheng, R Zhang, Q Jiang, G Du… - Advanced …, 2023 - Wiley Online Library
Triple‐negative breast cancer (TNBC) has higher molecular heterogeneity and metastatic
potential and the poorest prognosis. Because of limited therapeutics against TNBC …

E3 ubiquitin ligase RNF126 affects bladder cancer progression through regulation of PTEN stability

H Xu, L Ju, Y Xiong, M Yu, F Zhou, K Qian… - Cell Death & …, 2021 - nature.com
E3 ubiquitin ligase RNF126 (ring finger protein 126) is highly expressed in various cancers
and strongly associated with tumorigenesis. However, its specific function in bladder cancer …

[HTML][HTML] E2F3 induces DNA damage repair, stem-like properties and therapy resistance in breast cancer

L Wei, Y Bai, L Na, Y Sun, C Zhao, W Wang - Biochimica et Biophysica Acta …, 2023 - Elsevier
Therapy resistance is a major hurdle to the treatment of human malignant tumors. Both DNA
damage repair and stem-like properties contribute to chemoresistance and radioresistance …

Upregulation of DARS2 by HBV promotes hepatocarcinogenesis through the miR-30e-5p/MAPK/NFAT5 pathway

X Qin, C Li, T Guo, J Chen, HT Wang, YT Wang… - Journal of Experimental …, 2017 - Springer
Background Infection with the hepatitis B virus (HBV) is closely associated with the
development of hepatocellular carcinoma (HCC). The osmoregulatory transcription factor …

GADD45g acts as a novel tumor suppressor, and its activation suggests new combination regimens for the treatment of AML

D Guo, Y Zhao, N Wang, N You, W Zhu… - Blood, The Journal …, 2021 - ashpublications.org
Acute myeloid leukemia (AML) is an aggressive hematopoietic malignancy for which there is
an unmet need for novel treatment strategies. Here, we characterize the growth arrest and …

Ubiquitylation of Ku80 by RNF126 promotes completion of nonhomologous end joining-mediated DNA repair

N Ishida, T Nakagawa, SI Iemura, A Yasui… - … and cellular biology, 2017 - Taylor & Francis
Repair of damaged DNA is critical for maintenance of genetic information. In eukaryotes,
DNA double-strand breaks (DSBs) are recognized by the Ku70-Ku80 heterodimer, which …

A genome-wide pooled shRNA screen identifies PPP2R2A as a predictive biomarker for the response to ATR and CHK1 inhibitors

Z Qiu, P Fa, T Liu, CB Prasad, S Ma, Z Hong, ER Chan… - Cancer research, 2020 - AACR
There is currently a lack of precise predictive biomarkers for patient selection in clinical trials
of inhibitors targeting replication stress (RS) response proteins ATR and CHK1. The …